Avidity Biosciences
RNA
$24.36
Share price
2.22%
Change (1 day)
40.48%
Change (1 year)
Categories
Avidity Biosciences (RNA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.62 B
According to Avidity Biosciences's latest financial reports the company's total assets are $0.62 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Avidity Biosciences - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | -1.6% |
| 2022-12-31 | $0.63 B | 49.4% |
| 2021-12-31 | $0.42 B | 28.06% |
| 2020-12-31 | $0.33 B | 244.56% |
| 2019-12-31 | $96.9 M | 2333.63% |
| 2018-12-31 | $3.98 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 35,935.19% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 11,850.17% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $3.26 B | 419.38% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $1.89 B | 201.60% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.50 B | -19.46% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | -41.72% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.47 B | -25.21% | 🇺🇸 USA |